Vimarsana
Biggest News Aggregation in the World

Solid Form Patent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solid Form Patent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solid Form Patent Today - Breaking & Trending Today

Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2022 - Press Release - Vimarsana News

Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2022 - Press Release

Published: August 8, 2022

Cash runway extended through at least February 2023 based upon debt restructuring agreement with IPF Partners (IPF) and equity-linked financing facili

Source: wiredprnews.com
Related Topics:
France GeneralUnited KingdomUnited StatesSouth KoreaJohn KozarichThomas KuhnMerck SeronoSumitomo PharmaJanice BourquePierre LegaultTrademark OfficeInternational CongressDrug AdministrationFinancial PressBoard Of Directors The CompanyIris Capital InvestmentOrphan Drug DesignationSolid Form PatentChief Executive OfficerFast Track DesignationX Linked AdrenoleukodystrophyInherited Metabolic DiseaseExperimental TherapeuticsFirst HalfFollowing Upcoming
Poxel SA: Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2022 - Vimarsana News

Poxel SA: Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2022

Published: August 8, 2022

Cash runway extended through at least February 2023 based upon debt restructuring agreement with IPF Partners (IPF) and equity-linked financing facility with Iris Capital Investment (IRIS)

Source: finanznachrichten.de
Related Topics:
France GeneralUnited KingdomUnited StatesSouth KoreaArthur RouillJohn KozarichThomas KuhnMerck SeronoSumitomo PharmaJanice BourquePierre LegaultTrademark OfficeInternational CongressDrug AdministrationFinancial PressBoard Of Directors The CompanyIris Capital InvestmentOrphan Drug DesignationSolid Form PatentChief Executive OfficerFast Track DesignationX Linked AdrenoleukodystrophyInherited Metabolic DiseaseExperimental TherapeuticsFirst Half